Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results
Recently presented THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU) Strategic alternatives...
Recently presented THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU) Strategic alternatives...
SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology...
Dear Shareholders, TAMPA, FL, March 27, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX) (“Wellgistics Health”), This time last...
Continued execution across Ampligen® (rintatolimod) clinical development programs in areas with critical unmet needs, especially in the high-value pancreatic cancer...
Chetan Pujara, Ph.D Chief Research & Development Officer, SpyGlass Pharma Dr. Pujara brings extensive industry experience to guide late-stage development...
COPENHAGEN, Denmark, March 27, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
Winter Park, Florida--(Newsfile Corp. - March 27, 2025) - Adia Nutrition Inc. (OTC Pink: ADIA), a leader in regenerative medicine...
DUBAI, UAE, March 27, 2025 /PRNewswire/ -- Hisense, a leading global consumer electronics brand showcased innovations at the Appliance &...
COLOGNE, Germany, March 27, 2025 /PRNewswire/ -- From March 25 to 29, 2025, DeepCare, a global leader in dental AI, showcases...
DALLAS, March 26, 2025 /PRNewswire/ -- Ventra Health ("Ventra"), a leading business solutions provider for facility-based physicians, announced today that it...